Marcus from Ireland

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

NantKwest, Inc. (NK) shares information

Nikola Corp is an electric vehicle manufacturer making 4-wheelers, jetski’s and military grade OHVs.A pioneer in electric off road and powersport applications.

NantKwest, Inc.

24h Change

-8.22 %


Live rate: Market closed

Stock data per Tuesday 4 Aug, 2020

-0.99 (-8.22%)
US Market is closed

Live Stock price in graph for NantKwest, Inc. (NK)

  • Latest Volume

    1,596,676 (-16.61 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change

    + 174.10 %

About Nikola Corp

After going up over 100% shortly after launching, Nicola corp shares are considered a risky bet by many investors.

Twitter: @nikolamotor
Instagram: @nikolamotorcompany

Potential risks to be aware of with this company/stock

– Super high valuation.

– Covid-19 might affect results with people going for cheaper alternatives or simply waiting to purchase any electric off road vehicles.

Potential upsides beneficial to the company/stock

+ Very unique niche.

+ Not many competitors doing electric ATV’s and electric jetski’s.

Quick links

Broker recommendations for NantKwest

The NantKwest, Inc. stock is rated at 1.5 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Tuesday 7 July, 2020 by a total of 2 brokers. This means that the consensus of the 2 different brokers is leaning toward to overweight (moderate buy).

0 (0%)
0 (0%)
1 (50%)
0 (0%)
1 (50%)

Price target by analysts

The 2 latest analyst estimates, per Tuesday 7 July, 2020, show the following high, low and average price targets.
Target Average: 10.75 USD
Target High: 18 USD
Target Low: 3.5 USD


Latest news about NantKwest, Inc.

Below you can find the most recent news posts about NantKwest, Inc., primarily from US and UK based news sources.

The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold

Tuesday, 21 July 2020, 13:58:40
Here’s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) AstraZeneca plc (NYSE: AZN ) ( announced positive Phase 1/2 readout for the coronavirus vaccine it is co-developing with the Oxford University) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (reacted to positive late-stage readout for BXCK501 in treating schizophrenia and bipolar disorder) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) Cytosorbents Corp Inc (NASDAQ: CTSO ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fortress Biotech (NASDAQ: FBIO ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Illumina, Inc.
— Benzinga Feeds

The top healthcare dealmaker at RBC says investors should be wary of inflated biotech stocks touting coronavirus vaccines and treatments

Tuesday, 14 July 2020, 17:01:19
There’s a biotech bubble forming around companies riding news on coronavirus vaccines and treatments, a top healthcare banker told Business Insider. As scores of drug developers have launched coronavirus vaccine and drug programs, retail investors have been swept into the excitement. That has sent company valuations soaring without the data to support it, and it’s getting in the way of potential deals, said Andrew Callaway, head of healthcare investment banking at RBC Capital Markets. “The valuations of some of these companies make absolutely no sense,” Callaway said. While the banker didn’t name companies, there have been a handful of tiny biotechs with soaring stocks in 2020. These companies, like VaxArt, Novavax, and Altimmune, have not previously brought a vaccine to market. Visit Business Insider’s homepage for more stories . Andrew Callaway, head of healthcare investment banking at RBC Capital Markets, is no optimist when it comes to the countless biotech companies riding news on coronavirus vaccines and treatments while their stocks climb by hundreds of percentage points.
— Business Insider

The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan’s Botox Gets Label Expansion, 3 IPOs

Friday, 10 July 2020, 13:25:13
Here’s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
— Benzinga

The race for coronavirus treatments and vaccines is heating up. Here are the 9 most important events to watch for in July, from new vaccine trials starting to the first sales of a COVID-19 drug

Wednesday, 1 July 2020, 15:45:42
The summer will be a critical time for the race to develop effective coronavirus treatments and vaccines. Business Insider identified the nine most important events expected to happen in July. Expect a flood of data this month from vaccine and drug programs wrapping up clinical trials. Other promising therapeutics and vaccines are aiming to start human testing. And the speediest vaccine programs, like Moderna’s, will soon start massive late-stage trials — the crucial test in seeing how well these experimental shots work in humans. Visit Business Insider’s homepage for more stories . The dog days of summer are shaping into a critical stretch for developing COVID-19 drugs and vaccines. There are hundreds of research efforts across the world hunting for a potential cure. Business Insider reviewed what’s underway and identified the nine most important events slated for July. That includes potential vaccines from drugmakers like Johnson & Johnson starting human testing, while those that are farther along like Moderna’s experimental vaccine should be disclosing detailed results and even starting late-stage studies.
— Business Insider

ViewRay and NantKwest among healthcare gainers; Zynerba Pharmaceuticals leads the losers

Tuesday, 30 June 2020, 17:04:21
Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. NantKwe
— Seeking Alpha